Does TIRAGOLUMAB Cause Platelet count decreased? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Platelet count decreased have been filed in association with TIRAGOLUMAB. This represents 0.9% of all adverse event reports for TIRAGOLUMAB.
5
Reports of Platelet count decreased with TIRAGOLUMAB
0.9%
of all TIRAGOLUMAB reports
2
Deaths
3
Hospitalizations
How Dangerous Is Platelet count decreased From TIRAGOLUMAB?
Of the 5 reports, 2 (40.0%) resulted in death, 3 (60.0%) required hospitalization, and 3 (60.0%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIRAGOLUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TIRAGOLUMAB Cause?
Off label use (58)
Hyperthyroidism (39)
Pneumonia (29)
Pneumonitis (26)
Infusion related reaction (23)
Intentional product use issue (23)
Death (21)
Adrenal insufficiency (20)
Troponin increased (20)
Colitis (15)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which TIRAGOLUMAB Alternatives Have Lower Platelet count decreased Risk?
TIRAGOLUMAB vs TIRBANIBULIN
TIRAGOLUMAB vs TIRZEPATIDE
TIRAGOLUMAB vs TISLELIZUMAB
TIRAGOLUMAB vs TISOTUMAB VEDOTIN
TIRAGOLUMAB vs TISOTUMAB VEDOTIN-TFTV